These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 31300287)
21. Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified Vero-cell rabies vaccine (CPRV): a two-stage randomised clinical trial in the Philippines. Quiambao BP; Lang J; Vital S; Montalban CG; Le Mener V; Wood SC; Miranda E Acta Trop; 2000 Feb; 75(1):39-52. PubMed ID: 10708006 [TBL] [Abstract][Full Text] [Related]
22. A randomized open-label trial of 2-dose or 3-dose pre-exposure rabies prophylaxis among Thai children. Janewongwirot P; Jantarabenjakul W; Anugulruengkitt S; Anunsittichai O; Saengseesom W; Buranapraditkun S; Sophonphan J; Wacharachaisurapol N; Jitrungruengnij N; Pancharoen C; Puthanakit T Vaccine; 2019 Aug; 37(36):5307-5313. PubMed ID: 31358408 [TBL] [Abstract][Full Text] [Related]
23. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults. Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635 [TBL] [Abstract][Full Text] [Related]
24. Production of yellow fever virus in microcarrier-based Vero cell cultures. Souza MC; Freire MS; Schulze EA; Gaspar LP; Castilho LR Vaccine; 2009 Oct; 27(46):6420-3. PubMed ID: 19559120 [TBL] [Abstract][Full Text] [Related]
25. Purification of yellow fever virus produced in Vero cells for inactivated vaccine manufacture. Pato TP; Souza MCO; Mattos DA; Caride E; Ferreira DF; Gaspar LP; Freire MS; Castilho LR Vaccine; 2019 May; 37(24):3214-3220. PubMed ID: 31047674 [TBL] [Abstract][Full Text] [Related]
26. Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species. Malerczyk C; Freuling C; Gniel D; Giesen A; Selhorst T; Müller T Hum Vaccin Immunother; 2014; 10(10):2799-804. PubMed ID: 25483634 [TBL] [Abstract][Full Text] [Related]
27. Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium. Costa WA; Cunha RS; Bolzan VL; Silva Ade C; Caporale GM; Chaves LB; Oselka GW; Junqueira DA; Panacho MR; Dias RA; Takaoka NY Vaccine; 2007 Nov; 25(48):8140-5. PubMed ID: 18029066 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of Different Stabilizers and Inactivating Compounds for the Enhancement of Vero Cell Rabies Vaccine Stability and Immunogenicity: Olayan E; El-Khadragy M; Mohamed AF; Mohamed AK; Shebl RI; Yehia HM Biomed Res Int; 2019; 2019():4518163. PubMed ID: 31008105 [TBL] [Abstract][Full Text] [Related]
29. Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate. Fontana D; Kratje R; Etcheverrigaray M; Prieto C Vaccine; 2015 Aug; 33(35):4238-46. PubMed ID: 25869890 [TBL] [Abstract][Full Text] [Related]
30. Inactivation of rabies virus by hydrogen peroxide. Abd-Elghaffar AA; Ali AE; Boseila AA; Amin MA Vaccine; 2016 Feb; 34(6):798-802. PubMed ID: 26731189 [TBL] [Abstract][Full Text] [Related]
31. Production and evaluation of a chromatographically purified Vero cell rabies vaccine (PVRV) in China using microcarrier technology. Yu P; Huang Y; Zhang Y; Tang Q; Liang G Hum Vaccin Immunother; 2012 Sep; 8(9):1230-5. PubMed ID: 22894963 [TBL] [Abstract][Full Text] [Related]
32. A single center, open label study of intradermal administration of an inactivated purified chick embryo cell culture rabies virus vaccine in adults. Recuenco S; Warnock E; Osinubi MOV; Rupprecht CE Vaccine; 2017 Aug; 35(34):4315-4320. PubMed ID: 28688782 [TBL] [Abstract][Full Text] [Related]
33. Increasing Vero viable cell densities for yellow fever virus production in stirred-tank bioreactors using serum-free medium. Mattos DA; Silva MV; Gaspar LP; Castilho LR Vaccine; 2015 Aug; 33(35):4288-91. PubMed ID: 25930117 [TBL] [Abstract][Full Text] [Related]
34. [Biological characteristics of the adapted rabies virus 3aG-V in Vero cell]. Shi XS Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):348-50. PubMed ID: 15650786 [TBL] [Abstract][Full Text] [Related]
35. [The cultivation of the vaccinal rabies virus in continuous green monkey cell lines]. Aksenova TA; Khapchaev IuKh; Mironova LL; Soshenko IuV; Selimov MA; Khozinskiĭ VV Vopr Virusol; 1991; 36(5):432-3. PubMed ID: 1803782 [No Abstract] [Full Text] [Related]
36. An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system. Perrin P; Madhusudana S; Gontier-Jallet C; Petres S; Tordo N; Merten OW Vaccine; 1995 Sep; 13(13):1244-50. PubMed ID: 8578811 [TBL] [Abstract][Full Text] [Related]
37. Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines. Quiambao BP; Ambas C; Diego S; Bosch Castells V; Korejwo J; Petit C; Houillon G Vaccine; 2019 Apr; 37(16):2268-2277. PubMed ID: 30890382 [TBL] [Abstract][Full Text] [Related]
38. [Economical production of rabies vaccine on cell cultures]. Lalosević D; Lazarević-Ivanc L; Stankov S Med Pregl; 1997; 50(11-12):565-8. PubMed ID: 9471524 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of post-exposure vaccination against rabies in cattle. Basheer AM; Ramakrishna J; Manickam R New Microbiol; 1997 Jul; 20(3):289-94. PubMed ID: 9258949 [TBL] [Abstract][Full Text] [Related]
40. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells. Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]